Physicians and the pharmaceutical industry.

Por Dingle, B
Publicado em 1993

What are the factors that predict outcome at relapse after previous esophagectomy and adjuvant therapy in high-risk esophageal cancer?

Por Yu, E., Tai, P., Malthaner, R., Stitt, L., Rodrigues, G., Dar, R., Yaremko, B., Younus, J., Sanatani, M., Vincent, M., Dingle, B., Fortin, D., Inculet, R.
Publicado em 2010

Phase I study of concurrent and consolidation cisplatin and docetaxel chemotherapy with thoracic radiotherapy in non-small cell lung cancer

Por Zhang, T.W., Rodrigues, G.B., Louie, A.V., Palma, D., Dar, A.R., Dingle, B., Kocha, W., Sanatani, M., Yaremko, B., Yu, E., Younus, J., Vincent, M.D.
Publicado no Curr Oncol (2018)

Postoperative extended-volume external-beam radiation therapy in high-risk esophageal cancer patients: a prospective experience

Por Yu, E., Tai, P., Younus, J., Malthaner, R., Truong, P., Stitt, L., Rodrigues, G., Ash, R., Dar, R., Yaremko, B., Tomiak, A., Dingle, B., Sanatani, M., Vincent, M., Kocha, W., Fortin, D., Inculet, R.
Publicado em 2009